Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
BMC Cancer|April 30, 2026
De-escalation of adjuvant radio(chemo)therapy for patients with HPV-positive head and neck squamous cell carcinoma: study protocol for a phase I trial to reduce late toxicity (DELPHI)Annett Linge, Fabian Lohaus, Steffen Appold, et al.
BJU International|July 2, 2026
Ablative radiotherapy in castration-resistant prostate cancerTobias Hölscher, Fabian Lohaus, Lydia Koi, et al.
Clinical and Translational Radiation Oncology|November 21, 2022
Reduction of intrafraction pancreas motion using an abdominal corset compatible with proton therapy and MRISergej Schneider, Sarah Stefanowicz, Christina Jentsch, et al.
Clinical and Translational Radiation Oncology|April 17, 2018
Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapyAnnett Linge, Steffen Löck, Constanze Krenn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Utility of fiducial markers for target positioning in proton radiotherapy of oesophageal carcinomaRudi Apolle, Stefan Brückner, Susanne Frosch, et al.
European Urology Oncology|November 17, 2021
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical TrialTobias Hölscher, Michael Baumann, Jörg Kotzerke, et al.
Cancers|May 14, 2022
Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)Tobias Hölscher, Michael Baumann, Jörg Kotzerke, et al.
Radiation Oncology (London, England)|August 1, 2021
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Minli Niu, Stephanie E Combs, Annett Linge, et al.
Journal of Thoracic Disease|December 23, 2017
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy"Juliane Hoerner-Rieber, Marciana Duma, Oliver Blanck, et al.
Clinical and Translational Radiation Oncology|April 18, 2019
Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapyAnnett Linge, Stefan Schmidt, Fabian Lohaus, et al.
Pageof 7